Clinical Trial Update: T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating autologous CD19-targeted CAR-T cells in pediatric and young adult patients with relapsed B-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Autologous CD19 CAR-T cell therapy (CD19-directed CAR-T cell)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Relapsed B-Cell Acute Lymphoblastic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING